面部经筋刺法结合牵正穴甲钴胺穴位注射治疗难治性面瘫的回顾性队列研究  

Retrospective Cohort Study of Encircling Needling Acupuncture Combined Acupoint Injection with Mecobalamin for Treating Refractory Facial Paralysis

作　　者：李凌鑫[1,2] 李润 何成奇 卢景康[1,2] 刘新宇 LI Lingxin;LI Run;HE Chengqi(Rehabilitation Medicine Center of West China Hospital Attached to Sichuan University,Chengdu Sichuan 610041,China;Sichuan Provincial Key Laboratory of Rehabilitation Medicine,Chengdu Sichuan,610041,China;Ji'nan University,Guangzhou Guangdong 510445,China)

机构地区：[1]四川大学华西医院康复医学中心,四川成都610041 [2]康复医学四川省重点实验室,四川成都610041 [3]暨南大学,广东广州510445 [4]甘肃省第二人民医院,甘肃兰州730000

出　　处：《四川中医》2022年第11期221-223,共3页Journal of Sichuan of Traditional Chinese Medicine

基　　金：成都市科技局,重点研发支撑计划(编号:2019-YF05-00061-SN);四川省卫计委,四川省干部保健课题(川干研2019-118)

摘　　要：目的:研究分析面部经筋刺法结合牵正穴甲钴胺穴位注射治疗难治性面瘫的临床疗效与安全性。方法:将60例难治性面瘫患者分为观察组和对照组各30例。观察组采用面部经筋刺法结合牵正穴甲钴胺穴位注射联合常规康复治疗,对照组采用常规康复治疗。主要观察指标为House-Brackmann量表功能值(H-B)、面部残疾指数评分(FDI)和临床总有效率。结果:两组基线资料均衡(P>0.05),具有可比性。组内比较,治疗后观察组三项指标均明显改善(P<0.05),临床总有效率90.00%,对照组FDIS无明显改善,总有效率73.33%。组间比较,观察组各项指标相比对照组均显著改善(P<0.05)。对颅脑创伤、术后难治性面瘫患者亚组分析提示,观察组疗效(83.33%)明显优于对照组(50.00%,P<0.05)。安全性评估结果显示两组治疗过程均无明显不良反应。结论面部经筋刺法结合牵正穴甲钴胺穴位注射治疗难治性面瘫,尤其是创伤性脑损伤、颅脑手术后患者具有较好的临床疗效和较高的安全性。Objectives:To study the clinical efficacy and safty of refractory facial paralysis with encircling needling acupuncture combined acupoint injection with Mecobalamin.Methons:A sample of 60 patients who had a diagonosis of refractory facial paralysis were randomized into 2 groups averagely.The experimental group(the Group E)was treated with encircling needling acupuncture combined acupoint injection with Mecobalamin and routine therapy of rehabilitation,the controlled group(the Group G)was treated with routine therapy of rehabilitation alone.And we choose(H-B),(FDI)scale and total clinical efficiency as observation indicators.Results:The two groups had the same baseline in several aspects for controlling variable(P>0.05),when we considered the time of intervention as the influence factor,we found the total indicators of the Group E improved(P<0.05)and the total clinical efficiency was 90.00%,the Group C showed only two indicators without FDIS improved obviously,and the efficiency was 73.33%.Equally,the Group E proved a more significant improvement than the Group C when we compared the two groups(P<0.05).When we considered the types of disease(especially traumatic brain injury,surgery,etc.)as the influence factor,we found all the indicators improved in the Group E which had 83.33%in efficiency and only FDIS had unobvious improvement in the Group C which the efficiency was 50.00%(P<0.05).Comparing the two groups,the first one had a more obvious result than the latter(P<0.05).Additionally,both of the two groups disappeared adverse reaction through the safety assessment.Conclusion:The cure has the safety and can relieve symptoms in patients who has diagnosed refractory facial paralysis,especially as the complication of traumatic brain injury,after craniofacial surgery.

关 键 词：经筋刺法 穴位注射法 难治性面瘫 

分 类 号：R246.6[医药卫生—针灸推拿学]